Month: September 2026

17 September 2026

HARGREAVE HALE AIM VCT PLC
(the “Company”)

DRIS Issue Price

The reference price of a new Ordinary Share under the Company’s Dividend Re-investment Scheme (“DRIS”) for the special dividend announced on 13 August 2026 (the “Dividend”) has been set at 31.50p.  This is the last published ex-dividend NAV per Ordinary Share, as at close of business on 16 September 2026.

Further information regarding the DRIS offered in respect of the Dividend can be found in the DRIS Mandate (the “DRIS Mandate“) available on the Company’s website to view and/or download at https://www.hargreaveaimvcts.co.uk/document-library/. The DRIS Mandate is also available on the National Storage Mechanism website at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

The payment date of the Dividend and the allotment date of the new Ordinary Shares, to be issued pursuant to the DRIS (the “New Ordinary Shares”), is 30 September 2026. The date for admission and dealing of the New Ordinary Shares is expected to be on or around 7 October 2026.

END

For further information, please contact:

Canaccord Genuity Asset Management Limited Abbe Martineau

aimvct@canaccord.com +44 20 7523 4525

LEI: 213800LRYA19A69SIT31        

THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA, ITALY, DENMARK, JAPAN, THE UNITED STATES, OR TO ANY NATIONAL OF SUCH JURISDICTIONS

Neuberger Private Equity Partners Announces Transaction in Own Shares

St Peter Port, Guernsey 17 September 2026

Neuberger Private Equity Partners Limited (“NBPE” or the “Company”) today announces details of Class A Shares bought back pursuant to general authority granted by shareholders of the Company on 11 June 2026 and the share buy-back agreement with Jefferies International Limited.

Transaction on London Stock Exchange

Date of purchase of Shares	16 September 2026
Number of Shares purchased	600,553 Class A Shares
Highest price/lowest price paid	£14.45 / £14.34
ISIN for the Shares	GG00B1ZBD492

All Class A Shares bought back will be cancelled. Following the cancellation, the number of outstanding Class A Shares is 38,092,007‬. The Company also has 3,150,408 Class A shares held in treasury. For reporting purposes under the FCA’s Disclosure Guidance and Transparency Rules the market should use the figure of 38,092,007 voting rights when determining if they are required to notify their interest in, or a change to their interest in the Company.

For further information, please contact:

NBPE Investor Relations        +44 20 3214 9002
Luke Mason        NBPrivateMarketsIR@nb.com

Oak Group        +44 1481 723450

        NBPEP@oak.group

About Neuberger Private Equity Partners Limited

NBPE invests in direct private equity investments alongside market leading private equity firms globally. NB Alternatives Advisers LLC (the “Investment Manager”), an indirect wholly owned subsidiary of Neuberger Berman Group LLC, is responsible for sourcing, execution and management of NBPE. The vast majority of direct investments are made with no management fee / no carried interest payable to third-party GPs, offering greater fee efficiency than other listed private equity companies. NBPE seeks capital appreciation through growth in net asset value over time while paying a bi-annual dividend.

LEI number: 213800UJH93NH8IOFQ77

About Neuberger
Neuberger is an employee-owned, private, independent investment manager founded in 1939 with approximately 3,000 employees across 26 countries. The firm manages $567 billion of equities, fixed income, private markets, real estate and hedge fund portfolios for global institutions, advisors and individuals. Neuberger’s investment philosophy is founded on active management, fundamental research and engaged ownership. The firm is proud to be recognized for its commitment to its two constituents, clients and employees. Again this past year, we were named Best Asset Manager for Institutional Investors in the US (Crisil Coalition Greenwich) and the #1 Best Place to Work in Money Management (Pensions & Investments, firms with more than 1,000 employees). Neuberger has no corporate parent or unaffiliated external shareholders. Visit www.nb.com for more information, including www.nb.com/disclosure-global-communications for information on awards.
Data as of March 31, 2026.

Media Contacts:
US: Soogyung Jordan: Soogyung.Jordan@nb.com
EMEA: Fiona Kehily: Fiona.Kehily@nb.com

All Neuberger figures are as of March 31, 2026, unless otherwise noted, and are subject to change without notice. The firm data, including employees and assets under management, reflect the collective data of the various affiliated investment advisors who are subsidiaries of Neuberger Berman Group LLC. The company history/timeline includes the history of all the company’s subsidiaries, including predecessor companies and acquisitions.

This material is issued on a limited basis through various global subsidiaries and affiliates of Neuberger Berman Group LLC. Please visit www.nb.com/disclosure-global-communications to learn about each company and the legal restrictions and restrictions. The name “Neuberger Berman” and logo are registered service marks of Neuberger Berman Group LLC.

© 2026 Neuberger Berman Group LLC. All rights reserved.

This press release appears as a matter of record only and does not constitute an offer to sell or a solicitation of an offer to purchase any security.

NBPE is established as a closed-end investment company domiciled in Guernsey. NBPE has received the necessary consent of the Guernsey Financial Services Commission. The value of investments may fluctuate. Results achieved in the past are no guarantee of future results. This document is not intended to constitute legal, tax or accounting advice or investment recommendations. Prospective investors are advised to seek expert legal, financial, tax and other professional advice before making any investment decision. Statements contained in this document that are not historical facts are based on current expectations, estimates, projections, opinions and beliefs of NBPE’s investment manager. Such statements involve known and unknown risks, uncertainties and other factors, and undue reliance should not be placed thereon. Additionally, this document contains “forward-looking statements.” Actual events or results or the actual performance of NBPE may differ materially from those reflected or contemplated in such targets or forward-looking statements.

        PRESS RELEASE

                Paris, 17 September 2026

Ramsay Santé Group unveils “Connecting Care 2030” to drive next phase of profitable growth and create long term value for all stakeholders

• “Connecting Care 2030”, Ramsay Santé Group’s new strategic roadmap, leverages the transformation achieved through the successful execution of previous plan “Yes We Care 25”
• The updated strategy is built on five pillars that will drive both operational and financial performance, all anchored in medical excellence and Ramsay Santé Group’s unwavering ambition to deliver quality care, at every step, for everyone
• The new plan offers a clear path towards sustained topline growth and gradual margin improvement underpinned by a disciplined capital investment policy to strengthen its platform, support innovation and invest in the future of Healthcare
  • FY2029: Revenue growth¹ c.3.0% per annum² and EBITDA margin gradually improving
  • Continued deleveraging, targeting Net debt³/EBITDA (pre-IFRS) <4.0x

Paris, September 17^th, 2026 – Ramsay Générale de Santé (“Ramsay Santé”) is hosting today its 2026 Capital Markets Day and presenting “Connecting Care 2030,” its new four-year strategic roadmap. The plan is designed to leverage the Group’s integrated European Healthcare platform, to improve patient outcomes and access to care while delivering sustainable profitable growth. It is anchored in Ramsay Santé Group’s ambition to deliver quality care, at every step, for everyone.

Next chapter of profitable growth and value creation for all stakeholders

Through the disciplined execution of its previous strategic plan, “Yes We Care 2025”, Ramsay Santé Group has grown in 5 years into a leading European Healthcare player, with differentiated positions in five countries including France and Sweden, serving more patients (from 9 to 13 million), establishing more care facilities (from 375 to 491) and patient satisfaction (NPS) rose by 2 points to reach +73.

Building on these achievements, Connecting Care 2030 puts medical excellence and patient-centered care at the heart of Ramsay Santé Group’s next phase of development while providing a clear path towards solid organic growth and sustainable margin expansion, through five clear strategic pillars:

• Strengthen the integrated and accessible Healthcare offering,
• Embrace the digital transformation of Healthcare delivery,
• Ensure active portfolio and contract management,
• Continue to focus on cost initiatives measures,
• Accelerate additional profitable growth through new revenue streams.

Pascal Roché, CEO of Ramsay Santé Group, commented: “Today, we are opening the next chapter of Ramsay Santé Group’s development with “Connecting Care 2030”, our new strategic plan designed to unlock the full potential of our Group. These past years we have successfully transformed the Group, building one of the leading and most integrated Healthcare platform in Europe. Connecting Care 2030 is about unlocking the full potential of that platform with a clear ambition: connecting more patients across a greater share of their care journey, expanding where we have structural headroom, developing new revenue streams, and leveraging digitalisation and productivity to translate growth into stronger profitability.

At the heart of this strategy is medical excellence, which underpins everything we do: continuously improving patient outcomes and safety, sharing best practices across our European network, and scaling clinical innovation, research and training. This commitment makes us the partner of choice for patients, physicians and employees, and a trusted reference partner for governments and healthcare systems, reflecting our critical role in delivering accessible and high-quality care across our markets.

Leveraging a unique model of cross-country innovation and knowledge sharing, “Connecting Care 2030” provides a clear path towards sustained organic growth, progressive margin improvement and continued deleveraging, supported by disciplined capital allocation, ultimately creating sustainable long-term value for all our stakeholders.”

Opportunities for new shareholders, alongside long-term shareholder Crédit Agricole Assurances⁴

The Capital Markets Day marks a new chapter for Ramsay Santé Group, as Ramsay Health Care (RHC), its current 52.79% majority shareholder, has announced its intention to distribute its entire stake in Ramsay Santé Group to its own shareholders. It should be done through an in-specie distribution expected to be implemented in December of this year⁵ and could result in a significantly broader shareholder base. Ramsay Santé has applied for a foreign exempt listing on the Australian Securities Exchange (ASX) through CHESS Depository Interests (CDIs).

With a long-time independent strategy, financing and governance framework, the Group enters this new phase from a solid financial position, further reinforced by its recent refinancing. In addition, Crédit Agricole Assurances⁶, which holds 39.82% of Ramsay Santé Group, has reaffirmed its commitment as a long-term shareholder and its confidence in the Group’s strategy, management and development potential.

A leading European healthcare platform

These last few years, Ramsay Santé Group has grown into a leading European Healthcare platform, with strong positions and systemic relevance. It operates in compelling European healthcare markets, underpinned by favourable demographics, powerful secular growth trends and high barriers to entry. Its leadership is underpinned by a number of distinctive strengths:

• Leading Healthcare platform of scale with systemic relevance
• Truly integrated care offering, anchored in medical excellence
• Partner of choice for patients, payors, doctors and employees
• At the forefront of digi-physical care and AI innovation to improve access, clinical decision-making, efficiency and continuity of care
• Solid financial performance with clear strategy and achievable milestones
• Highly experienced management team

As a mission-driven company creating lasting impact, Ramsay Santé Group has built a diversified and integrated care offering anchored in medical excellence and a proven model of cross-country digital innovation and knowledge sharing.

Throughout the last 3 years, the Group has shown a resilient growth and earnings profile, underpinned by successful performance initiatives and a strengthened and flexible balance sheet:

• Robust revenue growth in France, supported by sustained volume expansion in spite of a constrained tariff environment.
• Solid organic growth in the Nordics, driven by positive price and volume trends in Primary care, growing St Göran revenues and sustained demand across Group’s specialist clinics.
• Resilient profitability despite significant headwinds: successful performance plans have absorbed both the phase-out of temporary grants and underfunding of inflation.
• Stronger financial structure following the successful refinancing: debt maturities extended to 2033, a simpler capital structure.
• Significant financial flexibility from real estate, with €1.5bn of real-estate value.
• Clear ongoing deleveraging trajectory.

The five strategic pillars of “Connecting Care 2030” support quality and sustainable performance

Strengthen the integrated and accessible Healthcare offering.

Ramsay Santé Group will leverage its unique integrated offering, spanning the entire patient pathway, multiple patient entry points and a well-positioned asset base across major urban areas. This provides meaningful headroom to deepen its presence in existing markets by scaling care facilities where it already has established capabilities, while building on the core MSO network through Primary care in Sweden, and the continued roll-out of imaging capabilities.

Embrace the digital transformation of Healthcare delivery.

Ramsay Santé Group will further digitalise care pathways and embed data and AI across the platform, improving both the patient journey and the way care is delivered. This includes tele-tools and remote care, AI-enabled Primary care pathways and revenue-cycle management, as well as the broader deployment of digital and AI tools to simplify administrative processes, support clinical decision-making and improve operational efficiency.

Ensure active portfolio and contract management.

Ramsay Santé Group will continue to actively manage its existing asset and contract base—not simply expand it—to concentrate resources where they can generate stronger growth and returns. Continued portfolio optimisation and rationalisation will support margin improvement through better capacity utilisation, closer alignment of the activity mix with evolving patient demand, and a leaner, more efficient network footprint.

Continue to focus on cost initiatives.

Ramsay Santé Group will further embed targeted performance initiatives across France and the Nordics, with margin improvement driven not simply by cost reduction but by better utilisation of existing capacity, enhanced occupancy rates of operating theatres, better medical staff efficiency, procurement optimisation, improved administrative costs, workforce planning improvement, and more efficient workflows.

Accelerate additional profitable growth through new revenue streams.

Beyond growth from its existing activities, Ramsay Santé Group will develop complementary revenue streams that leverage the strength of its Healthcare platform. This includes expanding home-based care and Mental health day care, and developing private health insurance and occupational health offerings in Sweden, creating additional sources of profitable growth around the Group’s core activities.

Short and mid-term financial outlook

By leveraging its integrated healthcare offering, strengthening the core MSO network and investing into complementary activities, Ramsay Santé expects to deliver solid organic growth in the coming years. In parallel, the group will implement multiple levers to improve profitability while driving robust cash-flow generation, through disciplined capital allocation and streamlined financing mix and costs. Its short- and mid-term financial outlook is as follows:

• FY 2027: Revenue growth⁷ between 2.0% to 3.0% and stable EBITDA margin (vs. FY 2026)
• FY 2029: Revenue growth⁷ at c. 3.0% per annum⁸ and gradual EBITDA margin improvement
• Gross capex at approximately 4.0% of revenue on average over the FY 2027-FY 2029 period.

• Continued deleveraging, targeting net debt⁹ / EBITDA (pre-IFRS) below 4.0x.

The slide deck presentation and the Webcast of the Capital Markets Day are available here Webcast link and on our website Ramsay Santé EU AnalystsPresentation

Disclaimer

This press release may contain certain statements that are forward-looking. Such forward-looking statements are for illustrative purposes only. Such forward-looking statements involve significant risks, uncertainties and assumptions that could cause actual results to differ materially from the Company’s present expectations or projections, many of which are difficult to predict and generally beyond the control of Ramsay Santé. These risks and uncertainties include those discussed or identified under Chapter 3 of the Universal Registration Document of Ramsay Santé, filed with the French Autorité des marchés financiers (“AMF”) on 29th October 2025 under number D.25-0689 which is available on the websites of Ramsay Santé (www.ramsaysante.fr) and of the AMF (www.amf-france.org). Actual results and developments may differ materially from those expressed in, implied by or projected by forward-looking statements. Ramsay Santé does not undertake to update or revise the forward-looking statements that may be presented in this press release to reflect new information, future events or for any other reason. Any opinion expressed in this press release is subject to change without notice.

This press release does not contain or constitute an offer of securities for sale or an invitation or inducement to invest in any securities or other financial products in Ramsay Santé, in France, Australia, the United States or any other jurisdiction.

This press release is not intended to pre-empt the key disclosures that will be made in the demerger scheme booklet to be distributed by RHC (Demerger Booklet). Any decision made by RHC shareholders in connection with the proposed distribution should be made only on the basis of the Demerger Booklet. This press release is not relevant to and should not be relied upon in connection with voting on the proposed demerger.

About Ramsay Santé

Ramsay Santé is the European leader in private hospitalisation and primary care. With 40,000 employees and 10,000 practitioners, the group welcomes 13 million patients each year in 491 facilities across five countries (France, Sweden, Norway, Denmark and Italy).

As a mission-driven company, Ramsay Santé covers the entire care pathways in medicine, surgery, obstetrics, medical and rehabilitation care, mental health and primary care centers, with constant innovation to improves everyone’s health and ensures equitable access to secure and qualitative care.

Facebook: https://www.facebook.com/RamsaySante 
Instagram: https://www.instagram.com/ramsaysante 
LinkedIn: https://www.linkedin.com/company/ramsaysante 
YouTube: https://www.youtube.com/c/RamsaySante 

Code ISIN and Euronext Paris: FR0000044471 
Website:  www.ramsaysante.fr 

Investor / Analyst Relations        Press Relations

Clément Lafaix        Brigitte Cachon
Tél. +33 1 87 86 21 52        Tél. +33 1 87 86 22 11
clement.lafaix@ramsaysante.fr        brigitte.cachon@ramsaysante.fr

---

1 Excluding FX effect
2 CAGR FY2026-2029
3 Based on latest known tax framework (refer to page 4)
4 Through its subsidiary Predica.
⁵ The distribution is subject to satisfaction of customary conditions including RHC Board, RHC shareholder, Australian court and regulatory approvals.
6 Crédit Agricole Assurances confirmed that it did not intend to increase its shareholding in the Company or take control of it

7 Excluding FX effect
⁸ CAGR FY2026-2029
9 Based on latest known tax framework; in France, CVAE (Corporate Value-Added Tax) maintained over FY27-FY29; no renewal of the temporary/special CIT levy assumed after 2026

Attachment

• Ramsay Santé Group unveils Connecting Care 2030 – September 17 2026

17 September 2026

ICG plc (the “Company”)

Transaction in Own Shares, Completion of Share Buyback Programme and Total Voting Rights

The Company announces that on 9 September 2026, in accordance with the terms of its share buyback programme announced on 19 February 2026 (the “Share Buyback”), the Company has purchased 72,916 ordinary shares of nominal value of £0.2625 each in the capital of the Company (the “Ordinary Shares“) on the London Stock Exchange through Merrill Lynch International (“BofA Securities”).

The Share Buyback is to enable the Company to issue Ordinary Non-Voting shares to Amundi equal to the number of Ordinary Shares repurchased by the Company in a manner that is non-dilutive to the Company’s existing shareholders in connection with its strategic partnership with Amundi as announced on 18 November 2025 (the “Strategic Partnership Announcement”).

Aggregated Information

Date of Purchase:	Aggregate Number of Ordinary Shares Purchased:	Lowest Price Paid per Ordinary Share (GBP):	Highest Price Paid per Ordinary Share (GBP):	Volume-Weighted Average Price Paid per Ordinary Share (GBP):
9 September 2026	72,916	1914.00 pence	1981.00 pence	1941.95 pence

The Ordinary Shares acquired were initially held in Treasury and subsequently cancelled.

Schedule of Purchases

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the “Market Abuse Regulation”), (as in force in the UK and as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019), a full breakdown of the individual trades made by BofA Securities on behalf of the Company as part of the programme is detailed on the attached:

ICG PLC Weekly Trade Fills

Completion of Share Buyback Programme

The Company confirms that, following the purchase of the Ordinary Shares disclosed above, the Share Buyback has now concluded. Since the commencement of the Share Buyback, the Company has repurchased 15,280,825 Ordinary Shares in aggregate at a weighted average price of 1790.56 pence per Ordinary Share for a total consideration of approximately £274 million. In accordance with the Subscription Agreement, Amundi has subscribed for an equivalent number of Ordinary Non-Voting shares. The subscription price for those Ordinary Non-Voting shares was equal to the repurchase price for the Ordinary Shares, and Amundi will reimburse the Company in cash for the costs and expenses incurred in connection with the Share Buyback.

As a result of the completion of the Share Buyback, Amundi has a 9.9% economic interest in the Company, including a 4.9% voting interest. The Ordinary Shares and Ordinary Non-Voting shares have the same economic entitlements, including as relates to dividends. Shareholders may therefore use the figure of 290,644,122 (being the combined number of Ordinary Shares and Non-Voting Ordinary shares outstanding) to assess their economic interest in the Company.

Cancellation of Treasury Shares and Total Voting Rights

The Company confirms that on 16 September 2026, following the completion of the Share Buyback, it cancelled 6,897,364 Ordinary Shares held in Treasury. Following the cancellation, the Company has 275,363,297 Ordinary Shares in issue and 15,280,825 Ordinary Non-Voting shares in issue.

Therefore, the total number of voting rights in the Company is 275,363,297, and this figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA’s Disclosure Guidance and Transparency Rules.

No Ordinary Shares or Ordinary Non-Voting shares are currently held in Treasury.

Terms not defined here shall have the meaning as set out in the Strategic Partnership Announcement.

Enquiries:

Chris Hunt, Head of Corporate Development and Shareholder Relations, ICG
+44 (0) 20 3545 2020

Media:

Fiona Laffan, Global Head of Corporate Affairs, ICG
+44(0)20 3545 1510

Attachment

• ICG PLC Weekly Trade Fills

Not for release, publication or distribution, in whole or in part, directly or indirectly in, into or from any jurisdiction where to do so would constitute a violation of the relevant laws of such jurisdiction

Oslo, 17 September 2026 – DNO ASA, the Norwegian oil and gas operator, announces that the boards of DNO, DNO Bidco AS and Capricorn Energy plc have agreed a revision to the terms of the Acquisition announced on 1 September 2026 pursuant to which Capricorn Shareholders will be entitled to receive an amount equal to the full Acquisition Value in cash from Bidco.

The boards of the three companies believe that the Revised All-Cash Offer provides Capricorn Shareholders with greater certainty of value as compared to the Original Offer, as it is not reliant on the Capricorn Board being able to declare and pay the Permitted Dividend in full prior to the Effective Date.

The Capricorn Directors intend to recommend unanimously that Capricorn Shareholders vote in favour of the Scheme at the Court Meeting and the resolutions to be proposed at the General Meeting, each to be convened as soon as practicable.

The full announcement is attached.

– 

For further information, please contact:
Media: media@dno.no
Investors: investor.relations@dno.no

– 

DNO ASA is a Norwegian oil and gas operator active in the North Sea and the Middle East. Founded in 1971, DNO is Norway’s oldest oil company and the first to list on the Oslo Stock Exchange in 1981. The Company holds stakes in onshore and offshore licenses at various stages of exploration, development and production in Norway, the Kurdistan region of Iraq, the United Kingdom and Yemen. More information is available at www.dno.no.

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Attachment

• Revised Offer Announcement

ICG Enterprise Trust plc (the “Company”)

17 September 2026

Transaction in Own Shares

The Company announces that on 16 September 2026 it bought back 15,000 of its own shares under the long-term buyback programme, to be held as treasury shares, at an average price of 1408 pence per share.

Further details are set out below:

• Number of shares held as treasury shares following settlement of this purchase: 3,194,951
• Total shares in issue excluding treasury shares following settlement of this purchase: 60,359,241

The Company has bought back these shares under the authority granted by shareholders at its Annual General Meeting in June 2026, which permits the Company to repurchase a maximum of 14.99% of its ordinary shares. The actual number of shares repurchased by the Company will depend on market conditions. This authority lasts until the next shareholder authority granted (expected to be at the Annual General Meeting in 2027), or until expressly revoked by shareholders.

No maximum consideration payable has been determined by the Company, but the Company is unable to pay a price for any shares pursuant to the buyback which would equate to a premium to the net asset value. It is the Company’s current intention to hold any shares bought back in treasury.

The Company has instructed Numis Securities Limited (trading for these purposes as Deutsche Numis) as its broker in respect of its buyback transactions. This arrangement is in accordance with the UKLA Listing Rules and the Company’s general authority to repurchase shares.

Analyst / Investor enquiries:

Chris Hunt
Shareholder Relations, ICG
+44 (0) 20 3545 2020

Andrew Lewis
Company Secretary, ICG
+44 (0) 20 3545 1344

Media:

Clare Glynn
Corporate Communications, ICG
+44 (0) 20 3545 1395

Bang & Olufsen A/S has, pursuant to the Danish Capital Markets Act, received a major shareholder notification from UBS Group AG.

• As per 11 September 2026, UBS Group AG’s holding of shares and voting rights pursuant to section 38 of the Danish Capital Markets Act, as well as other financial instruments pursuant to section 39(2), was below 5 percent of the total share capital and voting rights in Bang & Olufsen A/S.

As of 11 September 2026, UBS Group AG held a total of 7,347,988 shares and voting rights in Bang & Olufsen A/S, corresponding to 4.99 percent of the total share capital and voting rights.

For further information, please contact:

Cristina Rønde Hefting
Sr. Director, Head of Strategy & Investor Relations
Phone: +45 4153 7303

Attachment

• BO_2616_Major shareholder announcement_UBS